Your Investor-Frist Strategy Partner
What We Do
Diligence & Transaction
(PE/VC)
Commercial Due Diligence
Strengthen investment case by validating the critical hypotheses on the target’s strategic defensibility and growth prospects
Business Plan Stress Test
Combine market and commercial evidence with historical performance to build an unbiased investor case with sensitivities
Corporate Finance & Processes
Valuation ranges and key drivers, synergy case quantification, vendor materials, data room and process management
Specialization: Growth equity in highly complex technologies and business models
Funding Readiness
(Scale-Ups)
Equity Story & Pitch Deck
Translate complex technology into an effective investor narrative that showcases the full potential of your innovation
Corporate Finance
Strengthen your position with scenario and milestone-based financial model, cap table sensitivities, deal structuring and term sheet review
Fundraising Strategy
Investor qualification and outreach plan, process orchestration, and your sparring partner to navigate investor conversations
Specialization: Deep Tech, Life Sciences
Value Creation
(Funds & Portfolio)
For PE Portfolio
Support your portfolio companies on market entry / GTM strategy and M&A topics such as exit preparation, strategic bolt-on
For Deep Tech Founders
Turn your technical / scientific breakthrough to real-world application by prioritizing the most impactful applications valued by the market
For GPs & Family Offices
Your sparring partner in sharpening LP narratives, stress testing investment thesis, and optimizing fund portfolio construction
Specialization: Portfolio value creation, business case development, investment management
Who I am
Aoraki Ventures is the independent investment and strategy advisory practice of Michael Zhang, CFA. Michael has 10 years of experience in M&A, strategy consulting, private equity, and venture capital.
Michael spent 5 years at Strategy& and PwC Deals, advising PE funds on 20+ M&A transactions with aggregate deal value over €1B. In 2021, Michael moved to the buy-side, leading early-stage investments in life sciences, deep tech, and digital infrastructure, and supporting portfolio companies from biotech company creation to scaling growth-stage platforms.
At Aoraki Ventures, Michael works with PE and VC funds on due diligence and investment strategy, and he supports portfolio companies on growth strategy, investor readiness, and fundraising. Aoraki Ventures always starts from an investor’s mindset and provide pragmatic advice that drives real decisions.
Sweet spots: Deep Tech, Life Sciences, Growth Equity
